These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9864283

  • 1. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    J Pharmacol Exp Ther; 1998 Dec; 287(3):983-7. PubMed ID: 9864283
    [Abstract] [Full Text] [Related]

  • 2. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [Abstract] [Full Text] [Related]

  • 3. Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Eur J Pharmacol; 1997 May 01; 325(2-3):137-44. PubMed ID: 9163560
    [Abstract] [Full Text] [Related]

  • 4. Effects of talipexole on contraversive rotation and functional impairment in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H, Kohno Y, Sasa M.
    Jpn J Pharmacol; 1998 Jul 01; 77(3):227-33. PubMed ID: 9717770
    [Abstract] [Full Text] [Related]

  • 5. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
    Kurlan R, Kim MH, Gash DM.
    Mov Disord; 1991 Jul 01; 6(2):111-8. PubMed ID: 2057003
    [Abstract] [Full Text] [Related]

  • 6. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y, Zhang Z, Ovadia A, Lapchak PA, Collins F, Hilt D, Lebel C, Kryscio R, Gash DM.
    Ann Neurol; 1997 Aug 01; 42(2):208-14. PubMed ID: 9266731
    [Abstract] [Full Text] [Related]

  • 7. Antiparkinsonian effects of BAM-1110, a novel ergoline derivative, in MPTP-treated cynomolgus monkeys.
    Kuno S, Mizuta E, Sakamoto H, Ichihara K, Nagasaka M.
    Clin Neuropharmacol; 1998 Aug 01; 21(1):35-40. PubMed ID: 9579283
    [Abstract] [Full Text] [Related]

  • 8. MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.
    Emborg-Knott ME, Domino EF.
    Exp Neurol; 1998 Aug 01; 152(2):214-20. PubMed ID: 9710520
    [Abstract] [Full Text] [Related]

  • 9. Trihexyphenidyl interactions with the dopamine D1-selective receptor agonist SKF-82958 and the D2-selective receptor agonist N-0923 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Ni L.
    J Pharmacol Exp Ther; 1998 Jan 01; 284(1):307-11. PubMed ID: 9435192
    [Abstract] [Full Text] [Related]

  • 10. Nicotine alone and in combination with L-DOPA methyl ester or the D(2) agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L, Zhang H.
    Exp Neurol; 1999 Aug 01; 158(2):414-21. PubMed ID: 10415147
    [Abstract] [Full Text] [Related]

  • 11. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
    Iravani MM, Tayarani-Binazir K, Chu WB, Jackson MJ, Jenner P.
    J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1225-34. PubMed ID: 16959959
    [Abstract] [Full Text] [Related]

  • 12. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B, Boucher R, Bédard PJ.
    Mov Disord; 1992 Dec 01; 7(1):43-7. PubMed ID: 1348351
    [Abstract] [Full Text] [Related]

  • 13. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours.
    Lane EL, Cheetham SC, Jenner P.
    Eur J Neurosci; 2005 Jan 01; 21(1):179-86. PubMed ID: 15654855
    [Abstract] [Full Text] [Related]

  • 14. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
    Goulet M, Madras BK.
    J Pharmacol Exp Ther; 2000 Feb 01; 292(2):714-24. PubMed ID: 10640310
    [Abstract] [Full Text] [Related]

  • 15. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
    Jenner P, Rose S, Nomoto M, Marsden CD.
    Adv Neurol; 1987 Feb 01; 45():183-6. PubMed ID: 2881443
    [No Abstract] [Full Text] [Related]

  • 16. Functional MRI of basal ganglia responsiveness to levodopa in parkinsonian rhesus monkeys.
    Chen Q, Andersen AH, Zhang Z, Ovadia A, Cass WA, Gash DM, Avison MJ.
    Exp Neurol; 1999 Jul 01; 158(1):63-75. PubMed ID: 10448418
    [Abstract] [Full Text] [Related]

  • 17. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    Blanchet PJ, Konitsiotis S, Whittemore ER, Zhou ZL, Woodward RM, Chase TN.
    J Pharmacol Exp Ther; 1999 Sep 01; 290(3):1034-40. PubMed ID: 10454475
    [Abstract] [Full Text] [Related]

  • 18. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Synapse; 2006 Sep 01; 60(3):239-50. PubMed ID: 16739115
    [Abstract] [Full Text] [Related]

  • 19. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C, Jiménez A, Tolosa E, Bonastre M, Bové J.
    Synapse; 2004 Feb 01; 51(2):140-50. PubMed ID: 14618681
    [Abstract] [Full Text] [Related]

  • 20. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF, Ni L.
    Exp Neurol; 1998 Aug 01; 152(2):238-42. PubMed ID: 9710523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.